Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
include: A motivation letter addressed to Dr Roderic Guigó A complete CV including contact details. Contact details of two referees. All applications must be addressed to Dr. Roderic Guigó and be submitted
-
-Coordinator for the Clinical Trials Unit of the Foundation, under the direction of Dr. Dolores Ochoa Mazarro. La Fundación de Investigación Biomédica del Hospital Universitario de la Princesa calls for a
-
Framework Programme? HE / ERC Is the Job related to staff position within a Research Infrastructure? No Offer Description The emerging ‘Synthetic Cell Programming’ lab, led by Dr. Santos-Moreno
-
the EU Research Framework Programme? H2020 / ERC Is the Job related to staff position within a Research Infrastructure? No Offer Description The emerging ‘Synthetic Cell Programming’ lab, led by Dr. Santos
-
Framework Programme? Not funded by an EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description The emerging ‘Synthetic Cell Programming’ lab, led by Dr. Santos
-
applicants are encouraged to engage in detailed discussions regarding the research project with Dr. Guang-Zhong Yin, the Host researcher. With a wealth of experience in MSCA proposal writing and application
-
to benefit from flexible working hours. Application Procedure All applications must include: A motivation letter addressed to Dr Roderic Guigó A complete CV including contact details. Contact details of two
-
superstructures” (Dr. Elena Pazos). Research Center: CICA (https://cica.udc.gal/en/ ), Universidade da Coruña (Spain) Starting Date: Between September and October, 2024. Terms and conditions: The PhD contract is
-
vacation period and the possibility to benefit from flexible working hours. Application Procedure All applications must include: A motivation letter addressed to Dr Roderic Guigó A complete CV including
-
FOLLOWING PROFILE: TECHNICIAN . Principal researcher: Dr. Emilio Alba Conejo/ Dr. Iñaki Comino Méndez. Location ONCO-1 Laboratory. Research group : IBIMA CODE: (CIMO-01). Clinical and Translational Cancer